Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: Results from the breakthrough generations study

American Journal of Epidemiology

Volumn 179, Issue 9, 2014, Pages 1128-1133

  Jones, Michael E ^a   Schoemaker, Minouk J ^a   Rae, Megan ^a   Folkerd, Elizabeth J ^a   Dowsett, Mitch ^a   Ashworth, Alan ^a   Swerdlow, Anthony J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

estradiol; reproducibility of results; testosterone

Indexed keywords

ESTRADIOL; LEPTIN; SEX HORMONE; TESTOSTERONE;

AGE CLASS; BLOOD; BODY MASS; CANCER; COHORT ANALYSIS; FAT; HEALTH RISK; SEASONALITY; SEX HORMONE; SMOKING; TEMPORAL ANALYSIS; WOMENS HEALTH;

ADULT; ARTICLE; BODY FAT; BODY MASS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MEASUREMENT; OBESITY; POSTMENOPAUSE; RELIABILITY; REPRODUCIBILITY; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM;

UNITED KINGDOM;

ESTRADIOL; REPRODUCIBILITY OF RESULTS; TESTOSTERONE;

ADIPOSITY; BODY MASS INDEX; ESTRADIOL; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TESTOSTERONE;

EID: 84899572985     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu027     Document Type: Article

References (40)

1. Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Endocr Relat Cancer. 2005;12(4):1071-1082.
2. Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384-398.
3. Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606-616.
4. Zhang X, Tworoger SS, Eliassen AH, et al. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat. 2013;137(3):883-892.
5. Tworoger SS, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev. 2006;15(9): 1578-1581.
6. Rosenberg CR, Pasternack BS, Shore RE, et al. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol. 1994;140(6):518-525.
7. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005;97(10):755-765.
8. Endogenous Hormones and Breast Cancer Collaborative Group. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14(10):1009-1019.
9. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420-428.
10. Kim MY, Zeleniuch-Jacquotte A. Correcting for measurement error in the analysis of case-control data with repeated measurements of exposure. Am J Epidemiol. 1997;145(11): 1003-1010.
11. Cauley JA, Gutai JP, Kuller LH, et al. Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol. 1991;133(1):50-57.
12. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer. 2004;90(1):153-159.
13. Hankinson SE, Manson JE, Spiegelman D, et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev. 1995;4(6):649-654.
14. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer. 1997;76(3):401-405.
15. Toniolo P, Koenig KL, Pasternack BS, et al. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev. 1994;3(1):47-50.
16. Falk RT, Brinton LA, Dorgan JF, et al. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res. 2013;15(2):R34.
17. Folkerd EJ, Martin L-A, Kendall A, et al. The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer. J Steroid Biochem Mol Biol. 2006;102(1-5):250-255.
18. Swerdlow AJ, Jones ME, Schoemaker MJ, et al. The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br J Cancer. 2011;105(7):911-917.
19. Dowsett M, Goss PE, Powles TJ, et al. Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res. 1987;47(7):1957-1961.
20. Jones ME, Schoemaker M, Rae M, et al. Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. J Clin Endocrinol Metab. 2013;98(7): 2967-2974.
21. Rinaldi S, Geay A, Déchaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1): 1065-1071.
22. SAS Institute, Inc. SAS 9.2 Help and Documentation. Cary, NC: SAS Institute, Inc.; 2010.
23. Koopmans LH, Owen DB, Rosenblatt JI. Confidence intervals for the coefficient of variation for the normal and log normal distributions. Biometrika. 1964;51(1-2):25-32.
24. Dowsett M, Folkerd E. Deficits in plasma oestradiol measurement in studies and management of breast cancer. Breast Cancer Res. 2005;7(1):1-4.
25. Lee JS, Ettinger B, Stanczyk FZ, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab. 2006;91(10):3791-3797.
26. Rosner B, Willett WC. Interval estimates for correlation coefficients corrected for within-person variation: implications for study design and hypothesis testing. Am J Epidemiol. 1988; 127(2):377-386.
27. Kuller LH, Gutai JP. Re: "A prospective study of endogenous estrogens and breast cancer in postmenopausal women" [letter]. J Natl Cancer Inst. 1995;87(18):1414-1415.
28. Muti P, Trevisan M, Micheli A, et al. Reliability of serum hormones in premenopausal and postmenopausal women overa one-year period. Cancer Epidemiol Biomarkers Prev. 1996; 5(11):917-922.
29. Brinkman MT, Baglietto L, Krishnan K, et al. Consumption of animal products, their nutrient components and postmenopausal circulating steroid hormone concentrations. Eur J Clin Nutr. 2010;64(2):176-183.
30. Micheli A, Muti P, Pisani P, et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol. 1991;44(10):1055-1061.
31. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(suppl 3):S56-S59.
32. Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol. 1998;30(12):1285-1290.
33. Chahal HS, Drake WM. The endocrine system and ageing. J Pathol. 2007;211(2):173-180.
34. Onland-Moret NC, Peeters PH, van der Schouw YT, et al. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. J Clin Endocrinol Metab. 2005;90(3):1414-1419.
35. Brand JS, Chan MF, Dowsett M, et al. Cigarette smoking and endogenous sex hormones in postmenopausal women. J Clin Endocrinol Metab. 2011;96(10):3184- 3192.
36. Chan MF, Dowsett M, Folkerd E, et al. Usual physical activity and endogenous sex hormones in postmenopausal women: the European Prospective Investigation into Cancer-Norfolk Population Study. Cancer Epidemiol Biomarkers Prev. 2007; 16(5):900-905.
37. Panico S, Pisani P, Muti P, et al. Diurnal variation of testosterone and estradiol: a source of bias in comparative studies on breast cancer. J Endocrinol Invest. 1990;13(5): 423-426.
38. Bjørnerem A, Straume B, Oian P, et al. Seasonal variation of estradiol, follicle stimulating hormone, and dehydroepiandrosterone sulfate in women and men. J Clin Endocrinol Metab. 2006;91(10):3798-3802.
39. Monroe KR, Murphy SP, Henderson BE, et al. Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer. 2007;58(2):127-135.
40. Nagata C, Nagao Y, Yamamoto S, et al. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev. 2008;17(6): 1418-1423.